Missing antibodies: Why herd immunity may be “unachievable” without mass deaths or long-shot vaccine

herd immunity statistics health coronavirus aspire aspioneer jpg
Credit: Aspioneer
[A] study of more than 60,000 people estimates that around just 5% of the Spanish population has developed antibodies, the medical journal the Lancet reported.

Herd immunity is achieved when enough people become immune to a virus to stop its spread.

Around 70% to 90% of a population needs to be immune to protect the uninfected.

ADVERTISEMENT

“Despite the high impact of Covid-19 in Spain, prevalence estimates remain low and are clearly insufficient to provide herd immunity,” the study’s authors said in the report.

“This cannot be achieved without accepting the collateral damage of many deaths in the susceptible population and overburdening of health systems.”

There have been studies of a similar kind in China and the US and “the key finding from these representative cohorts is that most of the population appears to have remained unexposed” to the coronavirus, “even in areas with widespread virus circulation,” the Lancet article said.

ADVERTISEMENT
ADVERTISEMENT

Prof Danny Altmann, British Society for Immunology spokesperson and Professor of Immunology at Imperial College London, described the study as “sobering”.

Related article:  Why social distancing is so crucial in the fight against COVID-19

“Findings such as this reinforce the idea that faced with a lethal infection that induces rather short-lived immunity, the challenge is to identify the best vaccine strategies able to overcome these problems and stimulate a large, sustained, optimal, immune response in the way the virus failed to do,” Prof Altmann said.

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend